Vitrectomy outcomes are affected by retinoschisis in myopic macular holes

Article

Vitrectomy used to treat highly myopic macula holes (HMMHs) is negatively affected by retinoschisis.

Vitrectomy used to treat highly myopic macula holes (HMMHs) is negatively affected by retinoschisis, claims a study in the British Journal of Ophthalmology.

Dr Yasushi Ikuno et al., Department of Ophthalmology, Osaka University Medical School, Yamadaoka, Japan, performed a retrospective cross-sectional study on 22 eyes with HMMHs that underwent vitrectomy.

All eyes were split into two groups. Ten eyes were identified with retinoschisis and 12 did not have retinoschisis. Posterior staphyloma height was measured by optical coherence tomography (OCT). The surgical outcomes were postoperative final best-corrected visual acuity (BCVA) and reoperation rate.

Postoperative BCVA was strongly linked to presence or absence of retinoschisis and preoperative BCVA. The schisis group presented with a worse visual acuity and a greater posterior staphyloma height than the non-schisis group.

Highly myopic eyes presented with two types of macula holes with significantly different prognosis. The investigation suggests the careful interpretation of preoperative OCT images to identify accurate surgical results.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.